Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ForMune logo — Crafting Therapeutic Vaccines with Protein Extra Domain A of...

ForMune

Crafting Therapeutic Vaccines with Protein Extra Domain A of Fibronectin for Licensure to Pharma and Marketing Firms

Founded 2012 Series Unknown Total: $4.40M Biotechnology, Health Care +1

General Information

Company Name ForMune
Founded Year 2012
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series Unknown
Social

BounceWatch is an independent company data service, not affiliated with ForMune. To contact ForMune, visit formune.es.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About ForMune

ForMune, founded in 2012, is a biotechnology and healthcare startup that focuses on developing therapeutic vaccines using protein Extra Domain A of fibronectin. The company's slogan, "Crafting Therapeutic Vaccines with Protein Extra Domain A of Fibronectin for Licensure to Pharma and Marketing Firms," encapsulates its core mission. ForMune's business model involves developing molecules for subsequent licensing to pharmaceutical and marketing companies. The company has attracted significant investment, with the last investment totaling an impressive €4.40M in a Venture Round on 19 September 2012. The investment came from notable firms including Inveready, SODENA, and Fundación Caja Navarra. ForMune's unique focus on therapeutic vaccines and its successful track record in attracting substantial investment make it an intriguing prospect for venture capital firms seeking opportunities in the biotechnology and healthcare industries. As the company continues to develop and seek partnerships with pharmaceutical and marketing firms, it presents an appealing potential for further growth and success in the future.

Taxonomy: therapeutic vaccines, protein Extra Domain A, fibronectin, pharmaceutical companies, marketing companies, drug development

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 3
Investor Investor Investor
19 Sep 2012

ForMune Alternatives & Competitors

ForMune vs
Intersection Energy Technology LTD
Intersection Energy Technology LTD Taiwan

Utilizing the power more efficiently with ENPO Energy Storage

Seed
2 employees
Energy, Energy Storage
ForMune vs
Piagmo Technology
Piagmo Technology Turkey

Piagmo — Powering Engagement Through Gamification.

Pre Seed
2 employees
EdTech, Gaming
ForMune vs
SUPERMIND
SUPERMIND Finland

SUPERMIND - A software company specialied in assortment management, demand forecasting and automated...

3 employees
E-Commerce, Information Technology

FAQ About ForMune

Crafting Therapeutic Vaccines with Protein Extra Domain A of Fibronectin for Licensure to Pharma and Marketing Firms
ForMune was founded in 2012.
ForMune operates in the following industries: Biotechnology, Health Care, Health and Wellness.
ForMune has completed 1 funding round, raising a total of $4.40M. The latest funding stage is Series Unknown.
Top alternatives and competitors to ForMune include Intersection Energy Technology LTD, Piagmo Technology, SUPERMIND, airSales, Rythen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ForMune and Intersection Energy Technology LTD are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ForMune, https://bouncewatch.com/company/formune, updated 11 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes